naldemedine
FDA Approves Naldemedine for OIC in Adults With Chronic Noncancer Pain
The approval was based on reviewing data from three clinical trials showing the safety and efficacy of naldemedine ...
MARCH 24, 2017
Naldemedine Improves Opioid-Induced Constipation in Patients With Chronic Noncancer Pain
Naldemedine treatment for 12 weeks significantly relieved opioid-induced constipation compared with placebo, as ...
APRIL 27, 2016
Load more